Novel Management of Isotretinoin-Induced Hypertriglyceridemia in an Adolescent With Severe Acne

Haider A. , Shaw JC Treatment of acne vulgaris. JAMA. 2004;292:726-735.

Carleton BC , Smith MA , Gelin MN , Heathcote SC Paediatric adverse drug reaction reporting: understanding and future directions . Can J Clin Pharmacol. 2007;14:e45-e57.

McLane J. Analysis of common side effects of isotretinoin . J Am Acad Dermatol. 2001;45:S188-S194.

Fung MA , Frohlich JJ Common problems in the management of hypertriglyceridemia. CMAJ. 2002;167: 1261-1266.

Pejic RN , Lee DT Hypertriglyceridemia. J Am Board Fam Med. 2006;19:310-316.

Kunynetz RA A review of systemic retinoid therapy for acne and related conditions . Skin Therapy Lett. 2004;9:1-4.

Bigby M. , Stern R. Adverse reactions to isotretinoin: a report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol. 1998 ;18:543-552.

AccutaneRoche. Isotretinion 10 and 40mg Capsules USB Nodular/Inflammatory Conglobate Acne therapy [product monograph]. Mississauga, ON: HoffmanLaRoche; 2006.

Vahlquist C. , Lithell H. , Michaelsson G. , Selinus I. , Vahlquist A. , Vessby B. Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin. Acta Derm Venereol. 1987;67:139-144.

Valhquist C. , Michaelsoon G. , Valhquist A. , Vessy B. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins. Br J Dermatol. 1985;112:69-76.

Vu-Dac N. , Gervois P. , Torra IP , et al. Retinoids increase human apo C-III expression at the transcriptional level via retinoid X receptor: contribution to the hypertriglyceridemic action of retinoids. J Clin Invest . 1998;102: 625-632.

De Marchi MA , Maranhao RC , Brandizzi LI , Souza DR Effects of isotretinoin on the metabolism of triglycerides and on the lipid profile in patients with acne. Arch Dermatol Res. 2006;297:403-408.

Oliver JD , Rogers MP Effects of retinoic acid on lipoprotein lipase activity and mRNA level in vitro and in vivo. Biochem Pharmacol. 1993 ;45:579-583.

Cilla DD Jr , Gibson DM , Whitfield LR , Sedman AJ Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol. 1996 ;36:604-609.

Shitara Y. , Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006;112:71-105.

Bakker-Arkema RG , Davidson MH , Goldstein RJ , et al. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA. 1996;275:128-133.

Greene JP An adolescent with abdominal pain taking isotretinoin for severe acne . South Med J. 2006;99: 992-994.